| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |